Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
14-4
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Journals
Journal #577
advertisement
Journal of Ocular Pharmacology and Therapeutics
12
Showing records 1 to 12 |
Display all abstracts in
Journal of Ocular Pharmacology and Therapeutics
51902
Ocular Surface Disease and Glaucoma: How to Evaluate Impact on Quality of Life
Rossi GC; Pasinetti GM; Scudeller L; Bianchi PE
Journal of Ocular Pharmacology and Therapeutics
2013; 29: 390-394
51986
Black Currant Anthocyanins Normalized Abnormal Levels of Serum Concentrations of Endothelin-1 in Patients with Glaucoma
Yoshida K; Ohguro I; Ohguro H
Journal of Ocular Pharmacology and Therapeutics
2013; 29: 480-487
51658
The activity of lowering intraocular pressure of cassiae seed extract in a DBA/2J mouse glaucoma model
Horng CT; Tsai ML; Chien ST; Kao WT; Tsai MK; Chang TH; Chen FA
Journal of Ocular Pharmacology and Therapeutics
2013; 29: 48-54
51712
Resveratrol mitigates rat retinal ischemic injury: the roles of matrix metalloproteinase-9, inducible nitric oxide, and heme oxygenase-1
Liu XQ; Wu BJ; Pan WH; Zhang XM; Liu JH; Chen MM; Chao FP; Chao HM
Journal of Ocular Pharmacology and Therapeutics
2013; 29: 33-40
51705
Association of ocular hypotensive medication types with dynamic contour tonometry and goldmann applanation tonometry measurements in a glaucoma and ocular hypertensive population
Tzamalis A; Kynigopoulos M; Chalvatzis N; Dimitrakos S; Schlote T
Journal of Ocular Pharmacology and Therapeutics
2013; 29: 41-47
51950
Prostaglandin Analogs and Timolol-Fixed Versus Unfixed Combinations or Monotherapy for Open-Angle Glaucoma: A Systematic Review and Meta-Analysis
Quaranta L; Biagioli E; Riva I; Rulli E; Poli D; Katsanos A; Floriani I
Journal of Ocular Pharmacology and Therapeutics
2013; 29: 382-389
51713
Effect of Latanoprost on Central Corneal Thickness in Unilateral Normal-Tension Glaucoma
You JY; Cho BJ
Journal of Ocular Pharmacology and Therapeutics
2013; 29: 335-338
51667
The effects of prostaglandin analogues on intracellular Ca2+ in ciliary arteries of wild-type and prostanoid receptor-deficient mice
Abe S; Watabe H; Takaseki S; Aihara M; Yoshitomi T
Journal of Ocular Pharmacology and Therapeutics
2013; 29: 55-60
51668
Effects of black currant anthocyanins on intraocular pressure in healthy volunteers and patients with glaucoma
Ohguro H; Ohguro I; Yagi S
Journal of Ocular Pharmacology and Therapeutics
2013; 29: 61-67
51973
Hybrid Dendrimer Hydrogel/Poly(Lactic-Co-Glycolic Acid) Nanoparticle Platform: An Advanced Vehicle for Topical Delivery of Antiglaucoma Drugs and a Likely Solution to Improving Compliance and Adherence in Glaucoma Management
Yang H; Leffler CT
Journal of Ocular Pharmacology and Therapeutics
2013; 29: 166-172
51890
Extended Release of Timolol from Nanoparticle-Loaded Fornix Insert for Glaucoma Therapy
Jung HJ; Chauhan A
Journal of Ocular Pharmacology and Therapeutics
2013; 29: 229-235
51765
Subscleral Trabeculectomy with Mitomycin-C Versus Ologen for Treatment of Glaucoma
Marey HM; Mandour SS; Ellakwa AF
Journal of Ocular Pharmacology and Therapeutics
2013; 29: 330-334
Issue
14-4
Table of Contents
Editor's Selection
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement